Stephen Mandel Forma Therapeutics Holdings, Inc. Put Options Transaction History

Lone Pine Capital LLC

  • $12.7 Billion
  • Q1 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track Stephen Mandel's Portfolio

Track Stephen Mandel Portfolio

Follow Stephen Mandel (Lone Pine Capital LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lone Pine Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lone Pine Capital LLC and Stephen Mandel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email